Abstract
Mutant matrilin-3 (V194D) forms non-native disulphide bonded aggregates in the rER of chondrocytes from cell and mouse models of multiple epiphyseal dysplasia (MED). Intracellular retention of mutant matrilin-3 causes endoplasmic reticulum (ER) stress and induces an unfolded protein response (UPR) including the upregulation of two genes recently implicated in ER stress: Armet and Creld2. Nothing is known about the role of Armet and Creld2 in human genetic diseases. In this study, we used a variety of cell and mouse models of chondrodysplasia to determine the genotype-specific expression profiles of Armet and Creld2. We also studied their interactions with various mutant proteins and investigated their potential roles as protein disulphide isomerases (PDIs). Armet and Creld2 were up-regulated in cell and/or mouse models of chondrodysplasias caused by mutations in Matn3 and Col10a1, but not Comp. Intriguingly, both Armet and Creld2 were also secreted into the ECM of these disease models following ER stress. Armet and Creld2 interacted with mutant matrilin-3, but not with COMP, thereby validating the genotype-specific expression. Substrate-trapping experiments confirmed Creld2 processed PDI-like activity, thus identifying a putative functional role. Finally, alanine substitution of the two terminal cysteine residues from the A-domain of V194D matrilin-3 prevented aggregation, promoted mutant protein secretion and reduced the levels of Armet and Creld2 in a cell culture model. We demonstrate that Armet and Creld2 are genotype-specific ER stress response proteins with substrate specificities, and that aggregation of mutant matrilin-3 is a key disease trigger in MED that could be exploited as a potential therapeutic target.
Highlights
The chondrodysplasias are a clinically and genetically heterogeneous group of skeletal diseases that encompass over 300 different phenotypes [1]
Western blotting confirmed that the protein levels of both Armet and Creld2 were increased in the chondrocytes of Matn3 V194D mice compared with wild-type controls at birth and 5 days of age (Fig. 1A, 5 days and Supplementary Material, Fig. S1, new born)
This study demonstrates for the first time the genotype-specific upregulation and secretion of Armet and Creld2 in various cell and mouse models of genetic skeletal diseases
Summary
The chondrodysplasias are a clinically and genetically heterogeneous group of skeletal diseases (chondrodysplasias) that encompass over 300 different phenotypes [1]. Mutations within the genes encoding a variety of cartilage extracellular matrix (ECM) structural proteins can result in numerous chondrodysplasias. These include cartilage oligomeric matrix protein (COMP), matrilin-3 (MATN3) and type IX collagen, which result in pseudoachondroplasia (PSACH: OMIN 177170) and multiple epiphyseal dysplasia (MED: OMIN 132400, 600204, 607078 and 614135) [2]; and type X collagen that causes metaphyseal chondrodysplasia type Schmid (MCDS: OMIN 156500) [3]. The majority of disease-associated mutations in these genes cause misfolding of the respective proteins and their subsequent retention within the endoplasmic reticulum (ER) [4,5]. Mutant protein retention results in ER stress and can lead to an UPR,
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have